Overview

Genetic Counseling Market is poised to value over CAGR of over 13.8% during the forecast period 2022 to 2028.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Genetic Counseling Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Genetic Counseling Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

Major players included in the Genetic Counseling Market:
• AT-GC
• Ancestry
• Arup Laboratories
• Biron Health Group
• Color Genomics
• EasyDNA
• GenPath Diagnostics (an Opko Health Company)
• GeneDX (an Opko Health Company)
• GeneHealth UK
• GeneMatters
• GeneScreen
• Genome Medical
• InformedDNA
• Invitae Corporation
• Laboratory Corporation of America
• Metis Genetics
• MyOncoPath
• Quest Diagnostics Incorporated
• Veritas Genetics
 (Note: The list of the major players will be updated with the latest market scenario and trends)

Genetic Counseling Market Segmentation:
By Counseling Approach
• Integrated
• Independent
• Discretionary Genetic Counseling

By Key Players Business Model
• Core Genetic Counseling Companies
• Direct-to-Consumer Genetic Testing Companies
• Clinical Genetic Testing Companies

By Channel
• Providers
• Self-Referred Individuals

By Type of Service
• Risk Assessment
• Pharmacogenomics
• Other Genetic Counseling Services

By Application
• Proactive Risk Assessment
• GC For Intent-to-Treat Patients (ITT)
• Prenatal and Preconception Care
• Pediatric Care
• Other Genetic Counseling Applications

By Target Population Segment
• General Population
• Patient Population

By Level of Service
• Pre-counseling Support
• Post Counseling Support

By Region
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

Genetic Counseling Market Video Sample:

Competitive Landscape:
• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

FutureWise Key Takeaways:
• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

Objectives of the Study:
• To provide with an exhaustive analysis on the Genetic Counseling Market By Counseling Approach, By Key Players Business Model, By Channel, By Type of Service,  By Application, By Target Population Segment, By Level of Service and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:
• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents

1. Market Introduction
   1.1 Objectives of the Study 
   1.2 Market Definition 
   1.3 Market Scope 
       1.3.1 Years Considered for the Study
       1.3.2 Market Covered
   1.4 Currency 
   1.5 Limitations 
   1.6 Stakeholders 

2. Research Methodology 
   2.1 Research Data 
       2.1.1 Secondary Data
             2.1.1.1 Key Data from Secondary Sources
       2.1.2 Primary Data
             2.1.2.1 Key Data from Primary Sources
   2.2 Market Size Estimation 
   2.3 Market Breakdown and Data Triangulation 
   2.4 Assumptions for the Study  

3. Executive Summary
   3.1 Market Outlook
   3.2 Segment Outlook
   3.3 Competitive Insights

4. Global Genetic Counseling Market Variables, Trends & Scope
   4.1. Market Lineage Outlook
   4.2. Penetration and Growth Prospect Mapping
   4.3. Industry Value Chain Analysis
   4.4. Cost Analysis Breakdown
   4.5. Technology Overview
   4.6. Regulatory Framework
        4.6.1. Reimbursement Framework
        4.6.2. Standards and Compliances

5. Market Overview
   5.1. Market Dynamics
        5.1.1. Market Driver Analysis
               5.1.1.1. Increasing focus of Genetic Counseling Market Companies on Brand Protection
               5.1.1.2. Untapped Opportunities in Emerging Regions
        5.1.2. Market Restraint Analysis
               5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
        5.1.3. Industry Challenges
               5.1.3.1. Presence of Ambiguous Regulatory Framework

6. Global Genetic Counseling Market Analysis Tools
   6.1. Industry Analysis - Porter’s
        6.1.1. Supplier Power
        6.1.2. Buyer Power
        6.1.3. Substitution Threat
        6.1.4. Threat from New Entrants
        6.1.5. Competitive Rivalry
   6.2. Pestel Analysis
        6.2.1. Political Landscape
        6.2.2. Environmental Landscape
        6.2.3. Social Landscape
        6.2.4. Technology Landscape
        6.2.5. Legal Landscape
   6.3. Major Deals And Strategic Alliances Analysis
        6.3.1. Joint Ventures
        6.3.2. Mergers and Acquisitions
        6.3.3. Licensing and Partnership
        6.3.4. Technology Collaborations
        6.3.5. Strategic Divestments
   6.4. Market Entry Strategies
   6.5. Case Studies

7. Global Genetic Counseling Market, By Counseling Approach Historical Analysis and Forecast 2022-2028 (USD Million)
   7.1. Integrated
   7.2. Independent
   7.3. Discretionary Genetic Counseling

8. Global Genetic Counseling Market, By Key Players Business Model Historical Analysis and Forecast 2022-2028 (USD Million)  
   8.1. Core Genetic Counseling Companies
   8.2. Direct-to-Consumer Genetic Testing Companies
   8.3. Clinical Genetic Testing Companies

9. Global Genetic Counseling Market, By Channel Historical Analysis and Forecast 2022-2028 (USD Million)  
   9.1. Providers
   9.2. Self-Referred Individuals

10. Global Genetic Counseling Market, By Type of Service Historical Analysis and Forecast 2022-2028 (USD Million)  
    10.1. Risk Assessment
    10.2. Pharmacogenomics
    10.3. Other Genetic Counseling Services
  
11. Global Genetic Counseling Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)  
    11.1. Proactive Risk Assessment
    11.2. GC For Intent-to-Treat Patients (ITT)
    11.3. Prenatal and Preconception Care
    11.4. Pediatric Care
    11.5. Other Genetic Counseling Applications

12. Global Genetic Counseling Market, By Target Population Segment Historical Analysis and Forecast 2022-2028 (USD Million)  
    12.1. General Population
    12.2. Patient Population

13. Global Genetic Counseling Market, By Level of Service Historical Analysis and Forecast 2022-2028 (USD Million)  
    13.1. Pre-counseling Support
    13.2. Post Counseling Support

14. North America Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    14.1. Introduction
    14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          14.2.1. U.S.A
          14.2.2. Canada
          14.2.3. Mexico
    14.3. Market Size (USD Million) Forecast for North America 2022-2028

15. Latin America Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    15.1. Introduction
    15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          15.2.1. Brazil
          15.2.2. Venezuela
          15.2.3. Argentina
          15.2.4. Rest of Latin America
    15.3. Market Size (USD Million) Forecast for Latin America 2022-2028

16. Europe Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    16.1. Introduction
    16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          16.2.1. Germany
          16.2.2. U.K         
          16.2.3. France
          16.2.4. Italy
          16.2.5. Spain
          16.2.6. Russia
          16.2.7. Poland
          16.2.8. Rest of Europe
    16.3. Market Size (USD Million) Forecast for Europe 2022-2028

17. Asia Pacific Genetic Counseling Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    17.1. Introduction
    17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          17.2.1. Japan
          17.2.2. China
          17.2.3. India
          17.2.4. Australia and New Zealand
          17.2.5. ASEAN
          17.2.6. Rest of Asia Pacific
    17.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028  

18. Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    18.1. Introduction
    18.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
          18.2.1. GCC
          18.2.2. Israel
          18.2.3. South Africa
          18.2.4. Rest of MEA
    18.3. Market Size (USD Million) Forecast for MEA 2022-2028

19. Market Share Analysis and Competitive Landscape   
    19.1. Global Landscape - Key Players, Revenue and Presence
    19.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
    19.3. Global Emerging Companies
    19.4. North America - Market Share Analysis and Key Regional Players
    19.5. Europe - Market Share Analysis and Key Regional Players
    19.6. Asia Pacific - Market Share Analysis and Key Regional Players
    19.7. Global Key Player - Growth Matrix

20. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    20.1. AT-GC
          20.1.1. Company Overview
          20.1.2. Product Portfolio
          20.1.3. SWOT Analysis
          20.1.4. Financial Overview
          20.1.5. Strategic Overview
    20.2. Ancestry
          20.2.1. Company Overview
          20.2.2. Product Portfolio
          20.2.3. SWOT Analysis
          20.2.4. Financial Overview
          20.2.5. Strategic Overview 
    20.3. Arup Laboratories
          20.3.1. Company Overview
          20.3.2. Product Portfolio
          20.3.3. SWOT Analysis
          20.3.4. Financial Overview
          20.3.5. Strategic Overview
    20.4. Biron Health Group
          20.4.1. Company Overview
          20.4.2. Product Portfolio
          20.4.3. SWOT Analysis
          20.4.4. Financial Overview
          20.4.5. Strategic Overview
    20.5. Color Genomics
          20.5.1. Company Overview
          20.5.2. Product Portfolio
          20.5.3. SWOT Analysis
          20.5.4. Financial Overview
          20.5.5. Strategic Overview          
    20.6. EasyDNA
          20.6.1. Company Overview
          20.6.2. Product Portfolio
          20.6.3. SWOT Analysis
          20.6.4. Financial Overview
          20.6.5. Strategic Overview      
    20.7. GenPath Diagnostics (an Opko Health Company)
          20.7.1. Company Overview
          20.7.2. Product Portfolio
          20.7.3. SWOT Analysis
          20.7.4. Financial Overview
          20.7.5. Strategic Overview
    20.8. GenPath Diagnostics (an Opko Health Company)
          20.8.1. Company Overview
          20.8.2. Product Portfolio
          20.8.3. SWOT Analysis
          20.8.4. Financial Overview
          20.8.5. Strategic Overview 
    20.9. GeneHealth UK
          20.9.1. Company Overview
          20.9.2. Product Portfolio
          20.9.3. SWOT Analysis
          20.9.4. Financial Overview
          20.9.5. Strategic Overview
    20.10.GeneMatters
          20.10.1. Company Overview
          20.10.2. Product Portfolio
          20.10.3. SWOT Analysis
          20.10.4. Financial Overview
          20.10.5. Strategic Overview
    20.11.GeneScreen
          20.11.1. Company Overview
          20.11.2. Product Portfolio
          20.11.3. SWOT Analysis
          20.11.4. Financial Overview
          20.11.5. Strategic Overview
    20.12.Genome Medical
          20.12.1. Company Overview
          20.12.2. Product Portfolio
          20.12.3. SWOT Analysis
          20.12.4. Financial Overview
          20.12.5. Strategic Overview 
    20.13.InformedDNA
          20.13.1. Company Overview
          20.13.2. Product Portfolio
          20.13.3. SWOT Analysis
          20.13.4. Financial Overview
          20.13.5. Strategic Overview
    20.14.Invitae Corporation
          20.14.1. Company Overview
          20.14.2. Product Portfolio
          20.14.3. SWOT Analysis
          20.14.4. Financial Overview
          20.14.5. Strategic Overview
    20.15.Laboratory Corporation of America
          20.15.1. Company Overview
          20.15.2. Product Portfolio
          20.15.3. SWOT Analysis
          20.15.4. Financial Overview
          20.15.5. Strategic Overview          
    20.16.Metis Genetics
          20.16.1. Company Overview
          20.16.2. Product Portfolio
          20.16.3. SWOT Analysis
          20.16.4. Financial Overview
          20.16.5. Strategic Overview      
    20.17.MyOncoPath
          20.17.1. Company Overview
          20.17.2. Product Portfolio
          20.17.3. SWOT Analysis
          20.17.4. Financial Overview
          20.17.5. Strategic Overview
    20.18.Quest Diagnostics Incorporated
          20.18.1. Company Overview
          20.18.2. Product Portfolio
          20.18.3. SWOT Analysis
          20.18.4. Financial Overview
          20.18.5. Strategic Overview 
    20.19.Veritas Genetics
          20.19.1. Company Overview
          20.19.2. Product Portfolio
          20.19.3. SWOT Analysis
          20.19.4. Financial Overview
          20.19.5. Strategic Overview

21. Pre and Post COVID-19 Impact
    21.1. Positive influence on the healthcare industry
    21.2. The financial disruption of the manufacturing sector
    21.3. Impact of COVID-19 on emerging companies
    21.4. Significant mandates in the healthcare regulations initiated by administrations
    21.5. The overall economic slowdown of the developing and developed nations

22. FutureWise SME Key Takeaway Points for Client

Tables

Figures